Try it
Pharmacology · Antimicrobials: carbapenem-resistant organisms
Sample itemA patient in an Indian ICU has bacteraemia with a carbapenem-resistant Klebsiella carrying NDM-1 metallo-beta-lactamase. Which option is a recognised treatment approach?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Colistin-based or aztreonam combined with ceftazidime-avibactam
Metallo-beta-lactamases hydrolyse carbapenems and are not inhibited by avibactam, so aztreonam (stable to MBL) combined with ceftazidime-avibactam is used, with colistin and tigecycline as other options. India has a high NDM-1 prevalence.
Option by option
A. Ceftriaxone alone
Ceftriaxone is hydrolysed.
B. Colistin-based or aztreonam combined with ceftazidime-avibactam (correct)
Correct. These are recognised options for NDM producers.
C. Amoxicillin-clavulanate
Amoxicillin-clavulanate is ineffective.
D. Meropenem at higher doses alone
Carbapenems are hydrolysed by NDM.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?